MENU
+Compare
ACET
Stock ticker: NASDAQ
AS OF
Apr 2, 04:59 PM (EDT)
Price
$0.72
Change
-$0.02 (-2.70%)
Capitalization
59.86M

ACET Adicet Bio Forecast, Technical & Fundamental Analysis

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases... Show more

ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ACET with price predictions
Apr 01, 2025

ACET in +19.63% Uptrend, advancing for three consecutive days on March 24, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ACET advanced for three days, in of 268 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 31, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ACET as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ACET turned negative on April 01, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .

ACET moved below its 50-day moving average on March 27, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ACET crossed bearishly below the 50-day moving average on March 03, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACET declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ACET broke above its upper Bollinger Band on March 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ACET entered a downward trend on March 31, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.321) is normal, around the industry mean (13.458). P/E Ratio (0.000) is within average values for comparable stocks, (64.587). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.867). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (251.391).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ACET’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACET’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ACET is expected to report earnings to rise 4.37% to -33 cents per share on May 20

Adicet Bio ACET Stock Earnings Reports
Q1'25
Est.
$-0.33
Q4'24
Beat
by $0.03
Q3'24
Est.
$-0.34
Q2'24
Beat
by $0.03
Q1'24
Beat
by $0.10
The last earnings report on March 06 showed earnings per share of -31 cents, beating the estimate of -34 cents. With 303.46K shares outstanding, the current market capitalization sits at 59.86M.
A.I.Advisor
published Dividends

ACET paid dividends on October 09, 2018

Adicet Bio ACET Stock Dividends
А quarterly dividend of $0.01 per share was paid with a record date of October 09, 2018, and an ex-dividend date of September 21, 2018. Read more...
A.I. Advisor
published General Information

General Information

a distributor of pharmaceutical intermediate ingrediants and other industrial chemicals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Distributors
Address
131 Dartmouth Street
Phone
+1 650 503-9095
Employees
143
Web
https://www.adicetbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LVLU0.450.05
+12.50%
Lulu's Fashion Lounge Holdings
NATR12.970.42
+3.35%
Nature's Sunshine Products
COP105.390.37
+0.35%
ConocoPhillips
GSHD118.070.01
+0.01%
Goosehead Insurance
HQY87.05-1.32
-1.49%
HealthEquity

ACET and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ACET has been loosely correlated with ARWR. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ACET jumps, then ARWR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACET
1D Price
Change %
ACET100%
-2.65%
ARWR - ACET
42%
Loosely correlated
-4.20%
OGI - ACET
41%
Loosely correlated
+2.97%
DVAX - ACET
39%
Loosely correlated
-2.00%
CCCC - ACET
37%
Loosely correlated
-10.31%
CABA - ACET
36%
Loosely correlated
-15.52%
More